Johnson & Johnson (JNJ) Research & Development (2009 - 2026)

Johnson & Johnson has disclosed Research & Development across 18 years of filings, most recently posting $3.5 billion for Q1 2026.

• Research & Development for Q1 2026 came in at $3.5 billion, up 9.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $411.0 million (down 97.57% YoY), and the FY2025 annual result was $109.0 million, down 99.37% from the prior year.
• Research & Development came in at $3.5 billion for Q1 2026 at Johnson & Johnson, up from -$10.3 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $6.2 billion in Q1 2022 to a low of -$10.3 billion in Q4 2025.
• The 5-year median for Research & Development is $3.5 billion (2025), against an average of $2.3 billion.
• Across the five-year window, Research & Development sank 344.43% in 2023 and jumped 152.34% in 2024, its largest moves.
• Johnson & Johnson's Research & Development stood at $3.5 billion in 2022, then plunged by 390.44% to -$10.1 billion in 2023, then surged by 152.34% to $5.3 billion in 2024, then slumped by 294.49% to -$10.3 billion in 2025, then surged by 134.23% to $3.5 billion in 2026.
• The last three Research & Development figures came in at $3.5 billion (Q1 2026), -$10.3 billion (Q4 2025), and $3.7 billion (Q3 2025), per Business Quant data.